Annovis Bio Inc (ANVS:NYSE)
$2.81 0.10 (3.69%)
Analysed Annovis Bio Inc (ANVS:NYSE) News Sources
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
Yahoo Finance UK
Phenylketonuria Market to Reach New Heights by 2034, Driven by Innovative Therapies and Rising Diagnosis Rates | DelveInsight
The Malaysian Reserve
DelveInsight Business Research, LLP: Phenylketonuria Market to Reach New Heights by 2034, Driven by Innovative Therapies and Rising Diagnosis Rates | DelveInsight
FinanzNachrichten.de
Zydus launches India's first indigenously developed biosimilar - Anyra
Business Standard
Zydus Launches Biosimilar for Visual Impairment
Rediff Money
What is the current price of Annovis Bio Inc (ANVS:NYSE)?
The current price of Annovis Bio Inc (ANVS:NYSE) is $2.81.
Annovis Bio Inc (ANVS:NYSE) absolute price change since previous trading day?
The absolute price change of Annovis Bio Inc (ANVS:NYSE) since the previous trading day is $0.10.
Annovis Bio Inc (ANVS:NYSE) percentage price change since previous trading day?
The percentage price change of Annovis Bio Inc (ANVS:NYSE) since the previous trading day is 3.69%.
What is This Week's average sentiment score for Annovis Bio Inc (ANVS:NYSE)?
This Week's average sentiment score for Annovis Bio Inc (ANVS:NYSE) is 85 out of 100.
What is This Week's average sentiment for Annovis Bio Inc (ANVS:NYSE)?
This Week's sentiment for Annovis Bio Inc (ANVS:NYSE) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.